
Stryker Corporation
-0.78 %
9.05 %
Yet to be announced
Company Overview
Stryker Corporation operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Medsurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products. The Orthopsurgery segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries.
Revenue Sources
PassBased on analysis of Stryker's financial statements and product portfolio, the company's revenue is primarily derived from medical devices, surgical equipment, and related services. These are all halal products and services that contribute to healthcare and wellbeing. No evidence was found of revenue from haram sources such as alcohol, gambling, or other prohibited activities.
Reliance on Interest
Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
---|---|---|---|---|---|---|
March 31, 2025 | $5.87b | $5.03b | - | - | 0.00% | 0.00% |
Dec. 31, 2024 | $6.44b | $5.86b | - | - | 0.00% | 0.00% |
Sept. 30, 2024 | $5.49b | $4.41b | - | - | 0.00% | 0.00% |
June 30, 2024 | $5.42b | $4.37b | - | - | 0.00% | 0.00% |
Based on the financial data provided for the last four quarters, Stryker Corporation shows zero interest income and zero interest expense. This indicates that interest-based income and expenses are not material to the company's operations.
Operational Ethics
PassWhile Stryker operates globally, research does not indicate any substantial ongoing associations with entities involved in human rights violations. The company maintains standard business operations in various countries but no evidence was found of material ties to the Chinese Communist Party or current operations in Israel that would raise concerns.
Comments